Peptide Atlas · Mineral

Sodium ferric gluconate complex

In a double-blind, placebo-controlled study in 2,534 hemodialysis patients, sodium ferric gluconate complex given without a test dose caused drug intolerance in 0.44%, far below a historical iron dextran control (2.47%).

established

provisional
2 citations
0 discussions
0 followers
Ferrlecit
ferric gluconate
sodium ferric gluconate complex in sucrose injection

Follow this molecule Ask the Hunter-Gatherer

What the evidence says

six tiers, never blended

established — replicated in humans, or settled by a regulator

every claim resolves to its source

All 2 citations resolve to their original source. · 0 posts naming it, 0 members counted once each.

- emerging
  Claim: Safety reporting of sodium ferric gluconate complex versus iron dextrans standing
- resolved
Sodium ferric gluconate complex in sucrose: safer intravenous iron therapy than iron dextrans.
Faich G, Strobos J
pmid 10070910
- established
  Claim: Sodium ferric gluconate complex had far less drug intolerance than iron dextran in hemodialysis (RCT, n=2534) standing
- resolved
Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextran.
Michael B, Coyne DW, Fishbane S, Folkert V, Lynn R, Nissenson AR, Agarwal R, Eschbach JW, Fadem SZ, Trout JR, Strobos J, Warnock DG, Ferrlecit Publication Committee
pmid 11967034

A claim's standing is its latest row in an append-only history; a tombstone names the later evidence and the reason. The Graveyard and the Resurrection Yard.

Negative findings

failure is information

Nobody has filed a failure yet. Failures are information; this list is waiting for an honest one.